《“WCN24 - 843 超加工食品：慢性血液透析患者的决定因素及其与生化参数的关系”勘误》[第9卷，第4期，增刊，2024年4月，第S371页]
Corrigendum to "WCN24-843 ULTRAPROCESSED FOODS: DETERMINANTS AND RELATIONSHIP WITH BIOCHEMICAL PARAMETERS IN CHRONIC HEMODIALYSIS PATIENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S371].
作者信息
Nerbass Fabiana, Sczip Andrea, Morais Jyana, Calegari Adaiane, Kruger Tatiana, Oliveira Jorgiane, Scatone Natália, Dos Santos Rafaela, Barreto Fellype
机构信息
JOINVILLE, NUTRITION, Brazil.
Nutrition, CTDR, Mafra.
出版信息
Kidney Int Rep. 2024 Apr 18;9(6):1939. doi: 10.1016/j.ekir.2024.04.036. eCollection 2024 Jun.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2024.02.776.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2024.02.776。]
相似文献
1
Corrigendum to "WCN24-843 ULTRAPROCESSED FOODS: DETERMINANTS AND RELATIONSHIP WITH BIOCHEMICAL PARAMETERS IN CHRONIC HEMODIALYSIS PATIENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S371].《“WCN24 - 843 超加工食品：慢性血液透析患者的决定因素及其与生化参数的关系”勘误》[第9卷，第4期，增刊，2024年4月，第S371页]
Kidney Int Rep. 2024 Apr 18;9(6):1939. doi: 10.1016/j.ekir.2024.04.036. eCollection 2024 Jun.
2
Corrigendum to "WCN24-1066 BRIDGING THE GAP: INTEGRATING THE MULTIDISCIPLINARY EQUIPMENT ON HEMODIALYSIS VASCULAR ACCESS FROM LATIN AMERICA AND PERÚ" [ Volume 9, Issue 4, Supplement, April 2024, Page S379-S380].《“WCN24 - 1066弥合差距：整合拉丁美洲和秘鲁血液透析血管通路的多学科设备”勘误》[第9卷，第4期，增刊，2024年4月，第S379 - S380页]
Kidney Int Rep. 2024 Jun 3;9(8):2580. doi: 10.1016/j.ekir.2024.05.034. eCollection 2024 Aug.
3
Corrigendum to "WCN24-465 RISK OF MORTALITY IN PATIENTS RECEIVING HIGH-VOLUME ONLINE HEMODIAFILTRATION (OL-HDF) VERSUS HIGH-FLOW HEMODIALYSIS (HD) THERAPY IN 14 FRESENIUS MEDICAL CARE ECUADOR (FMC) CLINICS" [ Volume 9, Issue 4, Supplement, April 2024, Page S359].《“WCN24 - 465 厄瓜多尔费森尤斯医疗保健公司（FMC）14家诊所中接受高容量在线血液透析滤过（OL - HDF）与高流量血液透析（HD）治疗患者的死亡风险”勘误》[第9卷，第4期，增刊，2024年4月，第S359页]
Kidney Int Rep. 2024 Jun 6;9(8):2580-2581. doi: 10.1016/j.ekir.2024.06.001. eCollection 2024 Aug.
4
Corrigendum to "WCN24-2216 Clinical-surgical parameters in patients with arteriovenous fistulas failure in SERMESA'S nephrological centers during 2022" [ Volume 9, Issue 4, Supplement, April 2024, Page S411].《“2022年SERMESA肾脏病中心动静脉内瘘失败患者的临床手术参数”勘误》[第9卷，第4期，增刊，2024年4月，第S411页]
Kidney Int Rep. 2024 Apr 18;9(6):1940-1942. doi: 10.1016/j.ekir.2024.04.035. eCollection 2024 Jun.
5
Corrigendum to "WCN24-2021 KNOWLEDGE ATTITUDES AND BELIEFS ABOUT KIDNEY TRANSPLANTATION IN JAMAICAN RESIDENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S482].《牙买加居民对肾移植的知识、态度和信念》勘误 [第9卷，第4期，增刊，2024年4月，第S482页]
Kidney Int Rep. 2024 Jun 8;9(8):2582-2583. doi: 10.1016/j.ekir.2024.06.011. eCollection 2024 Aug.
6
Corrigendum to "WCN24-1675 ACUTE NECROTIZING ULCERATIVE GENGIVITIS IN KIDNEY TRANSPLANTATION: A CASE REPORT" [ Volume 9, Issue 4, Supplement, April 2024, Page S473].《肾移植中的急性坏死性溃疡性龈炎：一例报告》勘误 [第9卷，第4期，增刊，2024年4月，第S473页]
Kidney Int Rep. 2024 Apr 19;9(6):1937-1938. doi: 10.1016/j.ekir.2024.04.037. eCollection 2024 Jun.
7
Corrigendum to "WCN24-1065 QUALITY INDICATORS IN PERITONEAL DIALYSIS IN A CLINIC FROM FLORIANÓPOLIS, SANTA CATARINA, BRAZIL" [ Volume 9, Issue 4, Supplement, April 2024, Page S586].对《巴西圣卡塔琳娜州弗洛里亚诺波利斯一家诊所腹膜透析的质量指标》的勘误[第9卷，第4期，增刊，2024年4月，第S586页]
Kidney Int Rep. 2024 Apr 18;9(6):1943. doi: 10.1016/j.ekir.2024.04.033. eCollection 2024 Jun.
8
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [ Volume 9, Issue 4, Supplement, April 2024, Page S339].《“WCN24 - 1105 尼日利亚成年 HIV 感染者中替诺福韦诱导的肾小管功能障碍的药物遗传学风险因素”勘误》[第 9 卷，第 4 期，增刊，2024 年 4 月，第 S339 页]
Kidney Int Rep. 2024 May 17;9(7):2313-2314. doi: 10.1016/j.ekir.2024.05.018. eCollection 2024 Jul.
9
Corrigendum to "WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS" [ Volume 9, Issue 4, Supplement, April 2024, Page S637].《WCN24 - 1267 恩格列净改善内皮细胞活力并保护其免受晚期糖基化终末产物影响》勘误 [第9卷，第4期，增刊，2024年4月，第S637页]
Kidney Int Rep. 2024 Apr 29;9(7):2311. doi: 10.1016/j.ekir.2024.04.052. eCollection 2024 Jul.
10
Corrigendum to "WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS" [ Volume 9, Issue 4, Supplement, April 2024, Page S541].《“WCN24 - 2499 小窝蛋白 - 1 和小窝蛋白 - 2 作为大鼠急性胆汁淤积性肾损伤潜在尿液早期生物标志物”的勘误》[第9卷，第4期，增刊，2024年4月，第S541页]
Kidney Int Rep. 2024 Jun 8;9(8):2583-2584. doi: 10.1016/j.ekir.2024.06.012. eCollection 2024 Aug.
Zotero 插件